Novo Nordisk (NOVO B) DKK0.1 B

Sell:261.55 DKKBuy:261.60 DKKPrice increased13.25 DKK (5.37%)

Prices delayed by at least 15 minutes
Sell:261.55 DKK
Buy:261.60 DKK
Change:Price increased13.25 DKK (5.37%)
Deal now
Prices delayed by at least 15 minutes
Sell:261.55 DKK
Buy:261.60 DKK
Change:Price increased13.25 DKK (5.37%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open245.70 DKK
Previous close246.70 DKK
Market capDKK 836.34bn
P/E ratio9.55
Volume7,344,915
Dividend yield4.74%
EMS-

Company information

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through ...

  • LocationDenmark
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyDKK
  • Shares in issue3.39bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per shareDKK 7.95
  • Ex-dividend date27 March 2026
  • Payment date31 March 2026

Balance sheet 2025

Total assetsDKK 542.90bn
Total liabilitiesDKK 348.86bn
Net debtDKK 103.97bn

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.